Company News: Boehringer Ingelheim

Share this article:
The Boehringer Ingelheim-backed Drive4COPD awareness campaign is getting a big response through its use of social media, the company said. The campaign, which launched two weeks ago, has generated 27,000 completions of a validated five-question screener available at Drive4COPD.com, along with 1,400 Facebook fans, 25,000 clicks on campaign images at photo sharing site Flickr, 140,000 search results and 14,500 Twitter followers who've been exposed to some 50 Tweets from the campaign's celebrity ambassadors.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.